prednisone has been researched along with Adenocarcinoma Of Kidney in 31 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination of everolimus and low-dose prednisone administered daily was hypothesized to prevent noninfectious pneumonitis (NIP) and mucositis, two common adverse events related to everolimus." | 5.24 | A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer. ( Amadori, D; Barone, D; Burgio, SL; De Giorgi, U; Gallà, V; Lolli, C; Maugeri, A; Schepisi, G; Vertogen, B, 2017) |
| " A diagnosis of hypophysitis was made, and he was immediately started on prednisone 1 mg/kg." | 3.91 | Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis. ( Gallagher, EJ; Galsky, M; Leiter, A; Thapi, S, 2019) |
| "Five responses (lung metastases, three; lymph node metastases, two) were observed in 23 patients with metastatic renal cell carcinoma who received recombinant interferon-alpha-2A (IFN) 18 X 10(6) U in three intramuscular doses each week combined with oral prednisone (10 to 20 mg daily)." | 3.68 | Recombinant interferon-alpha combined with prednisone in metastatic renal cell carcinoma. Reduced toxicity without reduction of the response rate--a phase II study. ( Fosså, SD; Gunderson, R; Moe, B, 1990) |
| "Prednisone has been shown to decrease IFN-alpha-related toxicity without reducing the response rate." | 2.67 | Interferon-alpha, 5-FU and prednisone in metastatic renal cell carcinoma: a phase II study. ( Fosså, SD; Haarstad, H; Jacobsen, AB; Risberg, T; Schjølseth, SA, 1994) |
| "To evaluate the incidence, diagnosis and treatment of immune-related adverse events (e-irAE) of checkpoint inhibition (ICI) in metastatic urothelial carcinoma (mUC) and metastatic renal cell carcinoma (mRCC)." | 1.91 | Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors. ( Burger, M; Büttner, R; Oppolzer, IA; Riester, J; Schnabel, MJ, 2023) |
| "We describe a patient with metastatic renal cell carcinoma and a history of Crohn's disease who was treated with sunitinib and developed a severe exacerbation of Crohn's disease." | 1.40 | Severe exacerbation of Crohn's disease during sunitinib treatment. ( Boers-Sonderen, MJ; Hoentjen, F; Jacobs, JF; Mulder, SF; Nagtegaal, ID; van Herpen, CM; Wanten, GJ, 2014) |
| "In patient B, progression of renal cell carcinoma was found more than a half year later." | 1.36 | [Sweet syndrome in underlying malignancy]. ( Dercksen, MW; Nijziel, MR; Prins, M; ten Oever, J; van Hirtum, PV; Vreugdenhil, G, 2010) |
| "The histopathological diagnosis was renal cell carcinoma." | 1.31 | [Renal cell carcinoma in a patient with malignant lymphoma: a case report]. ( Senda, M; Takagi, Y; Tanaka, J, 2000) |
| "Treatment with aspirin and prednisone in one patient." | 1.29 | Anterior ischemic optic neuropathy secondary to interferon alfa. ( Purvin, VA, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.45) | 18.7374 |
| 1990's | 9 (29.03) | 18.2507 |
| 2000's | 7 (22.58) | 29.6817 |
| 2010's | 10 (32.26) | 24.3611 |
| 2020's | 3 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| Huynh, LM | 1 |
| Bonebrake, BT | 1 |
| DiMaio, DJ | 1 |
| Baine, MJ | 1 |
| Teply, BA | 1 |
| Oppolzer, IA | 1 |
| Riester, J | 1 |
| Büttner, R | 1 |
| Burger, M | 1 |
| Schnabel, MJ | 1 |
| Thapi, S | 1 |
| Leiter, A | 1 |
| Galsky, M | 1 |
| Gallagher, EJ | 1 |
| Remolina-Bonilla, YA | 1 |
| Jimenez-Franco, B | 1 |
| Lam, ET | 1 |
| Bourlon, MT | 1 |
| Lolli, C | 1 |
| Gallà, V | 1 |
| Schepisi, G | 1 |
| Barone, D | 1 |
| Burgio, SL | 1 |
| Maugeri, A | 1 |
| Vertogen, B | 1 |
| Amadori, D | 1 |
| De Giorgi, U | 1 |
| Ueharaguchi, Y | 1 |
| Kabashima, K | 1 |
| Sasahashi, M | 1 |
| Matsuda, A | 1 |
| Matubara, K | 1 |
| Matsui, M | 1 |
| Abrich, V | 1 |
| Duvuru, S | 1 |
| Swanson, HJ | 1 |
| Izzedine, H | 1 |
| Escudier, B | 1 |
| Rouvier, P | 1 |
| Gueutin, V | 1 |
| Varga, A | 1 |
| Bahleda, R | 1 |
| Soria, JC | 1 |
| Boers-Sonderen, MJ | 1 |
| Mulder, SF | 1 |
| Nagtegaal, ID | 1 |
| Jacobs, JF | 1 |
| Wanten, GJ | 1 |
| Hoentjen, F | 1 |
| van Herpen, CM | 1 |
| Piñar, D | 1 |
| Boix, E | 1 |
| Meana, JA | 1 |
| Herrero, J | 1 |
| van Hirtum, PV | 1 |
| Prins, M | 1 |
| ten Oever, J | 1 |
| Nijziel, MR | 1 |
| Vreugdenhil, G | 1 |
| Dercksen, MW | 1 |
| Maynard, JW | 1 |
| Christopher-Stine, L | 1 |
| Gelber, AC | 1 |
| Nadauld, LD | 1 |
| Miller, MB | 1 |
| Srinivas, S | 1 |
| Guo, R | 1 |
| Chang, L | 1 |
| Liu, Z | 1 |
| Li, AX | 1 |
| Huang, Q | 1 |
| Ann, DK | 1 |
| Wang, HC | 1 |
| Lin, CW | 1 |
| Wu, X | 1 |
| Yuan, YC | 1 |
| Yen, Y | 1 |
| Márquez Moreno, AJ | 1 |
| Mañas Uxó, J | 1 |
| Amores Ramírez, F | 1 |
| Aguilar Cuevas, R | 1 |
| Ortega Jiménez, MV | 1 |
| Leiva Vera, C | 1 |
| Pérez Rodríguez, D | 1 |
| Fujisawa, T | 1 |
| Aoshima, M | 1 |
| Uchiyama, N | 1 |
| Satoh, T | 1 |
| Ohmagari, N | 1 |
| Chonabayashi, N | 1 |
| Saiki, S | 1 |
| Suzuki, K | 1 |
| LAMBERG, BA | 1 |
| PELKONEN, R | 1 |
| FRICK, MH | 1 |
| Mohren, M | 1 |
| Essbach, U | 1 |
| Franke, A | 1 |
| Klink, A | 1 |
| Maas, C | 1 |
| Markmann, I | 1 |
| Pelz, AF | 1 |
| Jentsch-Ullrich, K | 1 |
| Christophersen, AO | 1 |
| Lie, AK | 1 |
| Fosså, SD | 4 |
| Phillips, PM | 1 |
| Newman, SA | 1 |
| Purvin, VA | 1 |
| Chu, SI | 1 |
| Kim, HJ | 1 |
| Skubitz, KM | 1 |
| Wong, MK | 1 |
| Bjarnason, GA | 1 |
| Hrushesky, WJ | 1 |
| Webster, P | 1 |
| Morava-Protzner, I | 1 |
| Towers, M | 1 |
| Dubernard, JM | 1 |
| Cloix, P | 1 |
| Tajra, LC | 1 |
| Alduglihan, W | 1 |
| Borson, F | 1 |
| Lefrançois, N | 1 |
| Martin, X | 1 |
| Haarstad, H | 1 |
| Jacobsen, AB | 1 |
| Schjølseth, SA | 1 |
| Risberg, T | 1 |
| Abouchacra, S | 1 |
| Duguid, WP | 1 |
| Somerville, PJ | 1 |
| Takagi, Y | 1 |
| Senda, M | 1 |
| Tanaka, J | 1 |
| Lehne, G | 1 |
| Gunderson, R | 2 |
| Hjelmaas, U | 1 |
| Holdener, EE | 1 |
| Zorn, BH | 1 |
| Taylor, RJ | 1 |
| Wood, RP | 1 |
| Stratta, RJ | 1 |
| Shaw, BW | 1 |
| Moe, B | 1 |
| Chasan, SA | 1 |
| Pothel, LR | 1 |
| Huben, RP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Study of Oral PRednisone 5 mg Bid Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of Vascular Endothelial Growth Factor Receptor-tyrosine Kinase Inhibitors[NCT02479490] | Phase 2 | 8 participants (Actual) | Interventional | 2015-09-22 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for prednisone and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
[A case of mediastinal metastasis of renal small cell carcinoma, performing CHOP therapy for an acute respiratory failure by the air way obstruction under the mechanical ventilation].
Topics: Acute Disease; Airway Obstruction; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal | 2003 |
Renal cell carcinoma presenting as nephrotic syndrome complicated by acute renal failure.
Topics: Acute Kidney Injury; Aged; Carcinoma, Renal Cell; Cyclophosphamide; Humans; Kidney Neoplasms; Male; | 1993 |
3 trials available for prednisone and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Everolimus; Female; | 2017 |
Interferon-alpha, 5-FU and prednisone in metastatic renal cell carcinoma: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug | 1994 |
Recombinant interferon alpha-2A combined with prednisone in metastatic renal-cell carcinoma: treatment results, serum interferon levels and the development of antibodies.
Topics: Antibody Formation; Carcinoma, Renal Cell; Female; Humans; Interferon alpha-2; Interferon-alpha; Int | 1992 |
26 other studies available for prednisone and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Development of bullous pemphigoid following radiation therapy combined with nivolumab for renal cell carcinoma: A case report of abscopal toxicities.
Topics: Aged; Antineoplastic Agents, Immunological; Carcinoma, Renal Cell; Doxycycline; Drug-Related Side Ef | 2021 |
Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors.
Topics: Antineoplastic Agents, Immunological; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Humans; H | 2023 |
Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
Topics: Adrenal Insufficiency; Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protoco | 2019 |
Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Hum | 2020 |
A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Eruptions; Humans; Indo | 2013 |
Limited scleroderma with pauci-immune glomerulonephritis in the presence of renal cell carcinoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2013 |
Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven.
Topics: Acute Kidney Injury; Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineopla | 2013 |
Severe exacerbation of Crohn's disease during sunitinib treatment.
Topics: Angiogenesis Inhibitors; Carcinoma, Renal Cell; Crohn Disease; Disease Progression; Fatal Outcome; G | 2014 |
Sunitinib-induced thyrotoxicosis.
Topics: Aged; Antineoplastic Agents; Carbimazole; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; | 2009 |
[Sweet syndrome in underlying malignancy].
Topics: Aged; Carcinoma, Renal Cell; Disease Progression; Follow-Up Studies; Humans; Kidney Neoplasms; Male; | 2010 |
Testicular pain followed by microscopic hematuria, a renal mass, palpable purpura, polyarthritis, and hematochezia.
Topics: Adrenal Cortex Hormones; Adult; Arthritis; Carcinoma, Renal Cell; Gastrointestinal Hemorrhage; Hemat | 2010 |
Pyoderma gangrenosum with the use of sunitinib.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Biopsy; Carcinoma, Renal Cell; Chemotherapy, Adjuva | 2011 |
Canonical nuclear factor κB pathway links tumorigenesis of synchronous mantle-cell lymphoma, clear-cell renal-cell carcinoma, and GI stromal tumor.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2011 |
[Synchronous chromophobe renal carcinoma and centrocytic lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Ther | 2003 |
HYPERCALCAEMIA IN RENAL CARCINOMA. REPORT OF A CASE.
Topics: Alkaline Phosphatase; Blood; Bone Neoplasms; Calcium; Carcinoma; Carcinoma, Renal Cell; Electrocardi | 1964 |
Acute myelofibrosis in a patient with diffuse large cell non Hodgkin's lymphoma and renal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Renal Cell; Chromosome Aberr | 2003 |
Unexpected 10 years complete remission after cortisone mono-therapy in metastatic renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Middle Aged; Neoplasm Regression, Spontaneo | 2006 |
Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma.
Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Dipho | 2008 |
Anterior ischemic optic neuropathy secondary to interferon alfa.
Topics: Acute Disease; Adult; Aspirin; Carcinoma, Renal Cell; Fundus Oculi; Humans; Interferon-alpha; Ischem | 1995 |
Pulmonary toxicity of continuous infusion 5-fluoro-2'-deoxyuridine.
Topics: Aged; Carcinoma, Renal Cell; Floxuridine; Humans; Infusions, Intravenous; Kidney Neoplasms; Lung Dis | 1995 |
Steroid-responsive interstitial lung disease in patients receiving 2'-deoxy-5-fluorouridine-infusion chemotherapy. A report of three cases.
Topics: Aged; Carcinoma, Renal Cell; Cough; Dyspnea; Female; Fever; Floxuridine; Forced Expiratory Volume; H | 1995 |
Simultaneous adrenal gland and kidney allotransplantation after synchronous bilateral renal cell carcinoma: a case report.
Topics: Adrenal Cortex; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Antilymphocyte Serum; Auto | 1995 |
[Renal cell carcinoma in a patient with malignant lymphoma: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cyclophosphamide; Doxor | 2000 |
Renal cell carcinoma in a liver transplant recipient.
Topics: Carcinoma, Renal Cell; Cholangitis, Sclerosing; Cyclosporins; Humans; Immunosuppression Therapy; Kid | 1991 |
Recombinant interferon-alpha combined with prednisone in metastatic renal cell carcinoma. Reduced toxicity without reduction of the response rate--a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Evaluation; | 1990 |
Management and prognostic significance of hypercalcemia in renal cell carcinoma.
Topics: Calcitonin; Calcium; Carcinoma, Renal Cell; Furosemide; Humans; Hypercalcemia; Indomethacin; Kidney | 1989 |